Because MT1-MMP, MMP-2 and MMP-9 are all overexpressed in invasive prostate cancers, it is likely that increased activation of MT1-MMP/MMP-2 complex also activates proMMP-9 and acts as a major mediator of pericellular proteolysis [13,25]. Here, MMP9 is linked to prostate carcinoma.